Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Saved in:
| Title: | Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment. |
|---|---|
| Authors: | Seitz CM; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Flaadt T; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Mezger M; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Lang AM; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Michaelis S; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Katz M; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Syring D; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Joechner A; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia., Rabsteyn A; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Siebert N; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Troschke-Meurer S; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Zumpe M; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Lode HN; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Yang SF; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia., Atar D; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Mast AS; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Scheuermann S; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Heubach F; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Handgretinger R; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Lang P; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schlegel P; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Department of Pediatric Hematology and Oncology, Westmead Children's Hospital, Westmead, NSW, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Jul 22; Vol. 12, pp. 690467. Date of Electronic Publication: 2021 Jul 22 (Print Publication: 2021). |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34367149 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Seitz+CM%22">Seitz CM</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Flaadt+T%22">Flaadt T</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mezger+M%22">Mezger M</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lang+AM%22">Lang AM</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Michaelis+S%22">Michaelis S</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Katz+M%22">Katz M</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Syring+D%22">Syring D</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Joechner+A%22">Joechner A</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Rabsteyn+A%22">Rabsteyn A</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Siebert+N%22">Siebert N</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Troschke-Meurer+S%22">Troschke-Meurer S</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Zumpe+M%22">Zumpe M</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Lode+HN%22">Lode HN</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Yang+SF%22">Yang SF</searchLink>; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Atar+D%22">Atar D</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mast+AS%22">Mast AS</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scheuermann+S%22">Scheuermann S</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Heubach+F%22">Heubach F</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Handgretinger+R%22">Handgretinger R</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lang+P%22">Lang P</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schlegel+P%22">Schlegel P</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Cellular Cancer Therapeutics Unit, Children's Medical Research Institute, Westmead, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Department of Pediatric Hematology and Oncology, Westmead Children's Hospital, Westmead, NSW, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Jul 22; Vol. 12, pp. 690467. <i>Date of Electronic Publication: </i>2021 Jul 22 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34367149 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2021.690467 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 690467 Titles: – TitleFull: Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Seitz CM – PersonEntity: Name: NameFull: Flaadt T – PersonEntity: Name: NameFull: Mezger M – PersonEntity: Name: NameFull: Lang AM – PersonEntity: Name: NameFull: Michaelis S – PersonEntity: Name: NameFull: Katz M – PersonEntity: Name: NameFull: Syring D – PersonEntity: Name: NameFull: Joechner A – PersonEntity: Name: NameFull: Rabsteyn A – PersonEntity: Name: NameFull: Siebert N – PersonEntity: Name: NameFull: Troschke-Meurer S – PersonEntity: Name: NameFull: Zumpe M – PersonEntity: Name: NameFull: Lode HN – PersonEntity: Name: NameFull: Yang SF – PersonEntity: Name: NameFull: Atar D – PersonEntity: Name: NameFull: Mast AS – PersonEntity: Name: NameFull: Scheuermann S – PersonEntity: Name: NameFull: Heubach F – PersonEntity: Name: NameFull: Handgretinger R – PersonEntity: Name: NameFull: Lang P – PersonEntity: Name: NameFull: Schlegel P IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 07 Text: 2021 Jul 22 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
